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ABSTRACT
Despite efforts to disseminate evidence-based psychological interventions (EBPIs) to
mental health practitioners, most individuals with psychological disorders do not receive any
form of treatment, and many others who do seek treatment do not receive EBPIs. The success of
the pharmaceutical industry in effectively marketing prescription drugs directly to consumers is
considered as a model for advancing dissemination of EBPIs. Utilizing undergraduate students as
participants, the current study examined how potential consumers of mental health services
respond to Internet-based marketing information about EBPIs. Participants viewed information
about anxiety disorders and a specific type of treatment (i.e., Cognitive-Behavioral Therapy) in
both text and video formats, with appeal type and tone as the independent variables. Dependent
measures assessed consumer attitude and evaluation, intent to try or recommend, and recall.
Multiple analyses of variance (ANOVAs) on these measures indicated that no one type of approach to
advertising is universally preferred, but respondents tended to respond more favorably in terms of positive
affect to emotional- and directive-based advertisements, and they were more likely to report an intent to
try CBT with text-based advertisements when compared to corresponding video-based information. The
results of the current study provide an important foundation for future research in direct-to-consumer
marketing of psychological treatments.
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I. INTRODUCTION
Recent decades have produced a significant wealth of information on the development of
effective psychological treatments, although progress disseminating and implementing these
types of treatments has been less successful (McHugh & Barlow, 2012). Despite the existence of
evidence-based psychological interventions (EBPIs) for a wide variety of specific problems,
most individuals with psychological disorders do not receive any form of treatment (Kessler et
al., 2005), and many others who do seek treatment do not receive EBPIs (Wang, Berglund, &
Kessler, 2000). This gap between treatments supported by research and actual implementation in
practice has generated an interest in developing more effective strategies for disseminating
information about EBPIs. One approach in particular, direct-to-consumer advertising, may
provide a promising new direction (Santucci, McHugh, & Barlow, 2012).
Direct-to-consumer (DTC) advertising refers to the marketing of specific prescription
drugs to the people who might use the medication as opposed to the medical professionals who
might prescribe it (FDA, 2012). Although these dissemination strategies are contemporary with
regard to clinical psychological research, the pharmaceutical industry provides an historic and
clear model for their efficacy. For example, the first printed newspaper advertisement in 1708
contained DTC marketing for a patented medicine, and this has remained a central component of
pharmaceutical advertising in the United States ever since (Bhanji et al., 2008). The
pharmaceutical industry has found that investment in this approach is fruitful, given that
Americans are much more likely to request specific drugs that they have seen advertised
(Gilbody, Wilson, & Watt, 2005) and also show a greater likelihood to learn about specific
1

health conditions based on the advertised medications used to treat them (Aikin, Swasy, &
Braman, 2004). Financially, spending on DTC advertisements has often resulted in great profits
to pharmaceutical companies, as drug sales have been demonstrated to return as much as four
times the advertising costs for certain medications (Kaiser Family Foundation, 2003).
Dowling (2004) describes the rationale behind DTC advertising as emphasizing “pull”
rather than “push” factors. A push strategy intends to increase a potential consumer’s awareness
of a product or service at the time of sale, as seen in traditional marketing efforts. The developer
of a treatment or service “pushes” the information to an intermediary, who then distributes it to
the end users. As Becker (2015) points out, this approach is typical for dissemination of mental
health services, since EBPIs are distributed to practitioners (the intermediary) who in turn
provide them to treatment-seeking individuals. Alternatively, DTC marketing relies on “pull”
factors, attempting to bring the consumer to the product or service more actively. This approach
circumvents the intermediary by directly targeting the end user of a specific service. The classic
“Ask your doctor about [drug name]...” advertisement illustrates this approach in practice with
respect to the pharmaceutical industry. Ventola (2011) notes that pharmaceutical companies
began using pull strategies using mass media after 1997, when the Food and Drug
Administration approved direct advertising of medications. Up to that point, a traditional
marketing strategy of sending representatives to primary care doctors and psychiatrists to “push”
their medications to patients was the dominant strategy. Although the drug industry has
emphasized DTC tactics to strong effect since they were made legal, it should also be noted that
combined push and pull approaches are still the norm and have been associated with significantly
increased sales during across the industry since the late 90s (Porter, 2011).
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The downside to the success of these marketing strategies is a potential overreliance on
medications among individuals who may not need psychotropic drugs (Moynihan & Cassels,
2005). For example, one study of DTC advertising found a 32% higher probability of being
prescribed an antidepressant based only on pharmaceutical marketing spending patterns,
suggesting increased diagnosis and prescription rates attributable directly to advertising about
specific antidepressant drugs (Donohue et al., 2004). This ability for DTC advertising to affect
physicians’ existing behavior and prescription patterns has been demonstrated to be sufficiently
pervasive that it has been determined to affect prevalence rates of mental illness. Park and Grow
(2008) surveyed consumers about their attitudes towards drug advertisements and found that
individuals who have a familiarity with specific prescription antidepressant brands are
significantly more likely to overestimate prevalence and risk of depression. Similarly, in a
comprehensive review of prescription trends, Rosenthal and colleagues (2003) used econometric
analysis to demonstrate changes in physician behavior, estimating that DCT advertising resulted
in a 13 to 22 percent increase in the overall spending on specific drug prescriptions written.
Thus, although the evidence regarding the effectiveness of these marketing strategies in
terms of economic indicators is apparent, the degree to which these methods provide consumers
with adequate information about the appropriate treatment for their individual problems is
unknown. To the extent that there are shortcomings, the types of changes seen in both consumer
as well as practitioner behavior suggest that DTC advertising is at least partially responsible for
limitations in knowledge related to these healthcare decisions. Kravitz and colleagues (2005)
suggest that DTC advertising has resulted in individuals receiving a particular drug if requested
by name even if that medication’s use is not supported for a specific disorder. Similarly, it has
been noted that off-label use of medications has been on the rise (Radley, Finkelstein, &
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Stafford, 2006), particularly with regard to psychotropic medications. In this latter group of
drugs, off-label usage has more than doubled over the past decade (Wu, Wang, Katz, & Farley,
2013), despite unfavorable side effects associated with off-label psychotropic regimens and a
necessary lack of clinical evidence for their efficacy (Alexander et al., 2011).
The move towards biomedical treatment for psychological problems is particularly
noteworthy with respect to anxiety disorders. Comer, Mojtabai, & Olfson (2011) found that over
a 12-year period, off-label antipsychotic use roughly doubled for the treatment of anxiety
disorders, a marked increase when compared to other disorders. Furthermore, in their review of
pharmacotherapy for mental health disorders, Ravindran & Stein (2010) found that selective
serotonin reuptake inhibitors (SSRIs), traditionally used in the treatment of depression, are often
considered first-line pharmacological treatments for anxiety disorders. Evidence suggests this
type of biomedical treatment of anxiety may be effective, especially when compared to other
pharmacological options (e.g., Bandelow, Boerner, Kasper, Linden, Wittchen, & Möller, 2013).
Unfortunately, these treatments often overlook potentially significant cognitive side effects, such
as memory impairment, inattentiveness, fatigue, lack of concentration, and apathy (Popovic,
Vieta, Fornaro, & Perugi, 2015). In fact, individuals with anxiety disorders are often uniquely
affected by certain SSRI side effects, such as jitteriness or restlessness (Farach et al., 2012).
At the same time, the past several decades have produced tremendous advances in
therapeutic EBPIs for anxiety-related problems, with specific treatments developed that have
shown considerable clinical efficacy (e.g., Butler, Chapman, Forman, & Beck, 2006; Chambless
& Hollon, 1998; Kendall, 2012; Lonigan, Elbert, & Johnson, 1998; Nathan & Gorman, 2007;
Roth & Fonagy, 2005). These types of treatments tend to be less costly to administer and
produce fewer side effects over the long term (e.g., Apeldoorn, Stant, Hout, Mersch, & den Boer,
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2014). Cost-effectiveness is a particularly important component of medical services, and existing
data indicate that CBT is a preferable option for both consumers and mental health providers
when considering the long-term costs of treatment (Heuzenroeder et al., 2004). However, despite
efforts to increase dissemination of EBPIs, progress improving service delivery of treatments has
been slow, especially with anxiety-related disorders (Beidas & Kendall, 2010). This deficit is
especially noteworthy given the high base rate of anxiety disorders (Kessler et al., 2005) and the
types of problems associated with biomedical approaches to treating anxiety. As a result,
research regarding direct-to-consumer advertising about EBPIs for psychosocial interventions
may be especially useful for improving delivery of the most effective treatments for anxiety
disorders.
Anxiety: Prevalence, Impact, and Treatment
Anxiety disorders are among the most common psychological disorders. Individuals
suffering from anxiety seek treatment from general medical health providers for their symptoms
as often as they do from mental health professionals (Shear, 1995). Anxiety disorders are
characterized by both psychological and physiological symptoms, including worrisome thoughts,
muscle tension, physical aches, sleeping difficulties, stomach problems, restlessness, and
irrational fears (American Psychiatric Association, 2013). These symptoms manifest with a wide
range of expression, including syndromes characterized by general worry about nonspecific
events to avoidance of specific fear-provoking stimuli. These various expressions of anxiety
collectively comprise the most commonly occurring psychological disorders, with some
estimates as high as 25% lifetime prevalence (Kessler et al., 1994). Specific phobia is generally
cited as the most common variety of focal anxiety disorder, occurring in 6-12% of individuals,
followed by social phobia, appearing in up to 10% of individuals. Post-traumatic stress disorder
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(PTSD), considered an anxiety disorder until DSM-5, is third most common, though lifetime
prevalence rates vary widely across different populations (i.e., 1-2% in Western Europe, 6-9% in
North America, and 10%+ in countries affected by longstanding conflict; Kessler et al., 1994).
Other anxiety disorders have much lower rates, rarely occurring above 2-3% with the exception
of panic disorder (2-5%) and generalized anxiety disorder (GAD; 3-5%; (Kessler et al., 2010).
In addition to the psychological burden imposed on individuals who suffer from these
afflictions, anxiety disorders are the source of great social and economic costs. With respect to
United States health care systems, anxiety disorders accounted for between $42.3 and $46.6
billion dollars spent in 1995 (DuPont et al., 1996), almost one-third of the $148 billion dollars
spent on overall mental health care at that approximate point in time (Greenberg et al., 1999).
Much of this cost comes from repeated use of health care services by the same individuals,
especially those with anxiety disorders that manifest symptoms similar to those of physical
illness or terminal disease (e.g., cardiac symptoms; Huffman, Pollack, Stern, 2002) In addition,
primary care physicians often fail to diagnose correctly many common anxiety-based disorders,
resulting in costly referrals to specialists like cardiologists, neurologists, and gastroenterologists
(Teng, Chaison, Bailey, Hamilton, & Dunn, 2008). Accordingly, the cost of visits of overall
health care services for individuals with anxiety disorders are on average twice as much as for
those without anxiety disorders (Simon et al., 1995). These costs have a significant impact on
employment (Lépine, 2002), productivity (Marciniak, Lage, Landbloom, Dunayevich, &
Bowman, 2004), and the ability for medical professionals to provide effective services (Teng et
al., 2008). However, a body of literature suggests anxiety disorders are highly treatable through
circumspect, time-limited, cost-efficient psychological interventions.
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Among the most supported psychosocial treatment approaches for anxiety disorders is
Cognitive-Behavioral Therapy (CBT). This general constellation of strategies differs somewhat
in accord with the type of anxiety disorder being treated, but all forms focus on ameliorating
symptoms by targeting underlying maladaptive cognitive processes and behavioral patterns that
contribute to psychological dysfunction. The CBT model posits that the symptoms of anxiety
disorders are both caused and maintained by fearful, maladaptive cognitions and that symptom
reduction can occur when these dysfunctional cognitions are modified through a number of
behavioral and cognitive techniques, especially exposure to feared stimuli (Beck, 1995; 2011).
CBT has been demonstrated to be effective in treating a broad range of disorders when compared
with waitlist and control conditions (Butler, Chapman, Forman, & Beck, 2006), as well as with
other forms of psychotherapy and pharmacological intervention (Butler, et al., 2006; Chambless
& Gillis, 1993). Major reviews (e.g., Hofmann & Smits, 2008) have concluded that CBT is an
efficacious treatment for anxiety disorders across clinical settings, diverse populations, and
different symptom presentations. Further, comparisons made in this meta-analysis demonstrated
that the observed outcomes produced medium to large effect sizes comparing treatment to
placebo control groups. Additionally, research suggests that CBT can produce equivalent or
better outcomes that endure longer at lower cost (Heuzenroeder et al., 2004). When considered in
the context of the necessarily time-limited nature of CBT, these findings of equivalent effects
promote considerable cost advantage for therapy over medication, given that effects for the latter
tend to diminish or disappear with the retraction of pharmacotherapy. Patients also tend to prefer
psychological treatments over pharmaceutical ones (McHugh, Whitton, Peckham, Welge, &
Otto, 2013), despite the potential success of pharmaceutical DTC strategies engendering greater
awareness of medical interventions. Although a complete review of the outcome literature is
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beyond the scope of this study, it bears noting that the American Psychological Association
(APA) categorizes CBT as a well-established and efficacious treatment for anxiety due to the
body of literature that has repeatedly demonstrated its superiority to other treatments (Chambless
& Ollendick, 2001). Other more contemporary methods of distilling treatment outcome research
for children and adolescents (Chorpita, Daleiden, & Weisz, 2005) have also demonstrated the
comparative efficacy of CBT techniques across treatment outcome studies in youth (Chorpita &
Daleiden, 2009).
Despite strong empirical support, CBT is measurably underutilized in clinical practice
(APA Task Force, 1994). Further, there is a broader trend of limited and/or non-effective service
delivery for these disorders in general. Data from the National Comorbidity Survey Replication
(NCS-R), for example, revealed that the majority of individuals suffering from a mental disorder
did not seek any form of treatment for their problem, and many of those who did received
“minimally adequate services” (Wang et al., 2005). Additionally, although general information
of mental health problems and psychotherapy as treatment have generally improved (e.g., Jorm,
Christensen, & Griffiths, 2006), public knowledge regarding effective types of mental health
care is still lacking (Sheyett, McCathy, & Rausch, 2006).
Therefore, it is unlikely than any given individual suffering from an anxiety-related
condition would seek out a specific evidence-based practice (i.e., CBT) in their attempts to
remedy their symptoms. Taken together, the extant research suggests that individuals who
present with psychological problems in medical settings are unlikely to receive appropriate
treatment given the types of services administered in these settings, the side effects and/or offlabel use of medications, and the generally limited set of psychosocial providers.
The Nature of Anxiety and the Case for Dissemination
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Barlow’s (2001) extensive examination of the history of anxiety explores the adaptive
value of emotional behavior and its role in the evolutionary success of animals (for example, fear
promoting the avoidance of threat through a fight or flight response). Various theoretical models
evaluate this response in terms of neurobiology (e.g., Eysenck, 1967; Gray, 1982; Kagan, 1989),
cognition (e.g,. Lazarus, 1991; Mandler, 1975; Schachter & Singer, 1962), and combinations of
biology and psychology (e.g., Beck, 1993; Hallam, 1985). Regardless of theoretical foundation,
the universality of this response as an adaptive mechanism is evident across cultures and species
(Izard, 1977). However, in individuals with anxiety disorders, this normal, adaptive response is
triggered in response to nonthreatening or otherwise inappropriate stimuli. Although it is a
complex biopsychosocial process, anxiety disorders most often manifest in the form of these
“false alarms.” Accordingly, one of the most common components of any evidence-based
treatment is to help individuals identify the basic elements of this process, such as antecedent
events that contribute to the expression of anxiety-related symptoms. Education about the nature
of anxiety as generally adaptive and potentially individually excessive forms the foundation for
effective psychotherapy for anxiety disorders (Foa & Kozak, 1985). A logical extension of this
educational strategy is to design exposure-based interventions to test assumptions regarding
legitimate vs. excessive estimations of threat. These approaches to treatment, which are primarily
based on cognitive-behavioral theory, are strongly supported by evidence and formally
considered first-line treatments (Institute of Medicine, 2008; Powers & Beacon, 2013).
Unfortunately, this is not well known in the general public despite greater efforts to improve the
dissemination and implementation of specific types of treatment (McHugh & Barlow, 2012).
Current research has begun to focus on increasing the spread of evidence-based
psychological interventions (EBPIs). Research efforts aimed to understand the spread of EBPIs
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in applied contexts are rooted in diffusion research, which frequently examines the rate at which
innovations are adopted and methods that most effectively propel this process (Rogers, 2003).
This adoption rate is contingent upon the integration of an innovation into daily life, the channels
through which information is communicated, and the success with which it is adopted by a group
of individuals working toward a common goal. This process often demands adaptation with
regard to mental health treatments, however, given several distinctions from other healthcare
services. These include increased stigma associated with diagnosis, less infrastructure for
measuring treatment quality, less communication among clinicians treating the same client, and a
more diverse workforce of providers from allied professions in terms of educational background
and degree of scientific training (Becker, 2015). Because of these particular obstacles, the
research-to-practice gap has been the primary focus of most dissemination efforts (Santucci,
McHugh, & Barlow, 2012). Clinician-administered interventions represent the predominant
focus of adherence to evidence-based practice guidelines as a means of promoting the use of
research-tested therapies. With treatment for particular disorders, service providers are seen as
the primary adopters who facilitate this integration and have accordingly been the primary
targets (Becker, 2015).
The majority of these dissemination efforts have targeted mental health providers in what
Gallo, Comer, & Barlow (2013) call a “top down” approach. These efforts have had some degree
of success, such as the nationwide initiative in the Veterans Health Administration (VA) to
implement a particular EBPI, Cognitive Processing Therapy (CPT), for the treatment of posttraumatic stress disorder. Resick, Foa, Ruzek, & Karlin (2008) found that 75% of practitioners
maintained adherence to the training they received in this specific EBPI, a rate much higher than
other, similar efforts (McHugh & Barlow, 2010). A preponderance of evidence from most other
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studies suggests, however, that these “top down” efforts do not achieve their intended goals as
effectively as possible. For example, many traditional training methods do not incorporate
essential active learning techniques, such as ongoing feedback and supervision, resulting in
lower rates of effective adherence (Beidas & Kendall, 2010). Other large-scale reviews have
demonstrated the gap between controlled research and actual clinical practice remains large (e.g.,
Kendall et al., 2008; Stewart & Chambless, 2007; Young et al., 2001). More sophisticated
methods of diffusion and dissemination, therefore, are necessary if practice is to become more
evidentiary in nature.
There are instances of programs of dissemination that have attempted to go beyond
providing clinicians with a greater access to evidence-based resources for mental health care to
facilitate a more integrative approach. For example, the United States federal government has
focused on empowering state mental health agencies (SMHAs) through various efforts to
disseminate EBPIs. Funding initiatives from federal agencies like the Substance Abuse and
Mental Health Services Administration (SAMHSA) and the National Institute of Mental Health
(NIMH) have been used to stimulate incorporation of training, resource kits, and structural
changes at the level of service providers. The National Implementing Evidence-Based Practices
Project was one such initiative that sought to develop, test, and refine the implementation of
specific resource kits (“toolkits”) for clinicians serving adults with severe mental illness (Rivard
et al., 2012). The primary focus of these efforts was to enable providers of mental health care
with the tools necessary for treating commonly presenting problems using EBPIs, but this
initiative was unique in its efforts by incorporating broader change at the structural level, as well
as attempting to involve consumers to a greater extent. Drake and colleagues (2009) found
variability in the program’s success and noted that several factors improved the quality of EBPI
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implementation, including funding, training, administrative support, and staff turnover.
Similarly, McHugo and colleagues (2007) documented results from all states involved in the
project and found that 55% of the participating sites had high fidelity of implementation, based
on independent interviews with key personnel and clients, chart reviews, and program
observations. Another study tracked the program after two years and found that there was a high
rate of sustainability for most EBPIs implemented (Swain et al., 2010). These research efforts
also demonstrated some of the barriers to successful implementation, including inadequate
funding, poorly supported training, lack of commitment from agency leadership, and staff
turnover (Swain et al., 2010). Effective implementation, on the other hand, has been
demonstrated by studies carefully selecting and training practitioners, organizing infrastructure
to ensure adequate support and supervision, and involving communities and consumers in the
selection and evaluation of programs (Fixsen, Naoom, Blase, Friedman, & Wallace, 2005). It has
also been noted, however, that these models are rarely followed in practice and sustainability of
EBPIs disseminated in training studies is limited (Bauer (2002; Miller, Sorensen, Selzer, &
Brigham, 2006; Pagoto et al., 2007).
Additionally, previous research suggests that little has been done to educate mental health
consumers about EBPIs. This second gap exists between those who need services and those who
seek them, referred to as “unmet need” or the “treatment gap” (Demyttenaere et al., 2004; Kohn,
Saxena, Levav, & Caraceno, 2004). As noted, the majority of individuals with a psychological
disorder in the United States do not receive treatments for their symptoms (McHugh & Barlow,
2012). Further, few have any framework to understand what sort of resources to seek (Becker,
2015), and limitations in healthcare service literacy for these issues are more significant in
minority groups (Kataoka, Zhang, & Wells, 2002; Sherbourne, Dwight-Johnson & Klap, 2001).
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Previous attempts to address this gap have not demonstrated measurable improvements; in fact,
the proportion of adults receiving therapy services in America has decreased over the past ten
years, from 7.4% of the population to 6.6% (Substance Abuse and Mental Health Services
Administration, 2013). As a result, there is clearly a need to expand the scope of dissemination
efforts to target consumers and provide greater information and awareness about the types of
treatment available for particular mental health disorders.
Direct-to-Consumer Advertising for Psychotherapy
The aforementioned success of the pharmaceutical industry suggests that direct-toconsumer advertising could provide a possible solution to the problem facing the effective
dissemination of psychological treatments (Santucci, McHugh, & Barlow, 2012). Although the
“top-down” approach that serves as the fundamental model for expanding the use of EBPIs is
certainly important, efforts that focus entirely on mental health providers are unlikely to remedy
the larger issue of unmet need presented by the treatment gap. There have been organizational
efforts to address limitations in public knowledge through the Anxiety and Depression
Association of America (ADAA) and the International Obsessive Compulsive Disorder
Foundation (IOCDF), for example. These professional groups have placed increased emphasis
on providing consumers with information about the types of services available; for example, the
IOCDF has hosted events, provided web resources, and expanded media coverage about CBT
techniques as a treatment for obsessive compulsive disorder (Szymanski, 2012).
The IOCDF uses a variation on the traditional conference or convention (at which
professionals gather to share and disseminate their research to their colleagues) by hosting an
annual conference of research presentations, talks, and other events to which consumers are
invited. This unique approach allows consumers to gain access to information about the latest
13

research and developments in OCD treatment, providing direct access to the professionals
involved in the field. Szymanski (2012) estimates that approximately one-third of attendees for
these events are mental health professionals, one-third are individuals with OCD, and one-third
are family members. While this arrangement seems to be an effective model to make annual
research conventions more consumer-friendly, the burden of time, travel, and logistics for the
individual who is interested in these resources means it is not a complete solution. Smaller-scale
presentations such as workshops hosted by university clinics (e.g., the Columbia University
Clinic for Anxiety and Related Disorders) could be a potential supplement to improving
consumer access to this essential information.
Research on the efficacy of DTC advertisements for psychological interventions is still in
its infancy, so there is no specific template to adopt for applying this idea for cognitivebehavioral therapy of anxiety disorders. Although the pharmaceutical industry has demonstrated
the effectiveness of simultaneous push and pull marketing techniques, psychotropic drugs have
the benefit of being a tangible product, which is more easily defined and described than
psychosocial interventions. EBPIs, however, are less easily evaluated by the typical consumer,
and as a service rather than a tangible product, psychotherapy is more difficult to describe in
terms of its moment-to-moment value. In addition, unlike the standardization of pharmaceutical
treatments, the delivery of psychological services can vary from provider to provider (Resick et
al., 2008). Thus, since research on DTC marketing for psychological services is a relatively
recent endeavor, crafting a suitable template for examining this research question is difficult.
However, literature from the advertising and marketing field, as well as the successful model
provided from psychopharmacology, can provide valuable insight into the development of a
similar approach for psychotherapy.
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The Marketing Mix
Adapting DTC marketing efforts to the field of psychological treatments has been
comparatively overlooked as a significant research interest. Gallo, Comer, and Barlow (2013)
outline some of the strategies used by organizations such as the IOCDF and the ADAA, but few
other large-scale efforts to incorporate pull-based DTC advertising efforts in clinical psychology
have been studied. In marketing literature generally, however, there are certain elements that
have been demonstrated to be effective. Zeithaml, Bitner, and Gremler (2012) describe this as
the “marketing mix,” one of the most commonly used planning frameworks for advertising. This
framework includes broad principles widely referred to as the “Four Ps”: product, price, place,
and promotion. As Becker (2015) argues, any DTC efforts for mental health services need to
focus on issues involving education about EBPIs, information about how to find and receive
those services, specific questions to ask about EBPIs, and criteria to allow the customer to ensure
they are receiving the services advertised. Traditional marketing theory provides a useful system
of guidelines in developing stimuli to meet this end, as evidenced by the material success
specific drugs marketed by pharmaceutical companies.
Product. Defining the service or product being marketed is a critically essential part of
effective DTC advertising. In the case of EBPIs, this component of marketing requires a decision
between advertising therapeutic services broadly and generally (e.g., CBT, Acceptance and
Commitment Therapy, family therapy) or in the form of specific interventions (e.g., exposure
and response prevention, mindfulness based stress reduction). Given limited consumer
knowledge about therapeutic treatments, a broad-based, general approach to disseminating
EBPIs for anxiety disorders may be the most effective initial step towards improving product
knowledge (i.e., it seems unlikely that advertisements about highly specific forms of treatment
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would resonate with the target audience). This approach could center on the fundamental factors
in anxiety that contribute to negative symptoms and general models used to address these
symptoms, with further information about specific types of treatment. As Donohue, Cevasco, &
Rosenthal (2007) demonstrated, pharmaceutical marketing efforts for one product increased
demand for the entire class of products—a phenomenon that may bolster treatment-seeking for
therapeutic services across all disorders as marketing for anxiety-related EBPIs expands. From a
treatment developer standpoint, successful advertising is contingent upon an examination of what
particular treatments are being disseminated and what services or other products currently exist
as competition. Describing the unique competitive advantage of therapeutic services relative to
other options for treatment is the key to defining this component of the marketing mix. From the
perspective of consumers, any effective advertisement should be able to answer questions about
what they value in a type of treatment, what options are available, and why they would select one
option over another. For example, it may be more beneficial to compare EBPIs to medication
rather than with one another; given the limited knowledge among consumers about differences in
therapeutic models, defining the service in this way may lead to greater treatment-seeking
behavior.
Price. Another key component of marketing, the price of goods and services is critical to
consumers in both a direct sense (i.e., what he or she must pay for that good or service) as well
as in terms of the barriers that may prevent treatment seeking. These barriers may be external,
such as difficulty in finding a provider, insurance coverage issues, or scheduling/time concerns,
or they may be internal, such as attitudes, beliefs, knowledge, etc. One limitation with
advertising therapeutic treatments is that prices are often set by third-party payers and insurance
carriers, giving treatment developers less autonomy in financial considerations. However,
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treatment developers and providers can help reduce other external barriers by decreasing the
difficulty of attending services (e.g., implementing technology, such as computer-assisted
therapy; locating services at locations where treatment-seeking is already occurring, such as
primary care offices, schools, etc.; and incorporating home-based components to treatment),
although some data exist that suggest the cost and price of services may not need to be low to
ensure improved treatment outcomes (e.g., Copeland, Hall, Didcott, & Briggs, 1993; Robart,
2014). A more relevant question for both treatment providers and potential consumers to
examine may be whether it is worth the costs to engage in a particular treatment. Providing
information educating consumers about the general price of services may be useful, but a more
effective strategy may be to emphasize the cost-effectiveness of EBPIs with respect to other
treatment options. These advertisements could also contain information about non-financial
costs, such as side effects from medications, as well as resources to assist with the reduction of
financial burdens (such as a “Find a therapist” option online to locate providers covered by
insurance).
Place. Place refers to both the channels through which information is disseminated, as
well as the actual location of the delivery of specific services. Marketing decisions about place
must carefully consider ways in which the information about a particular service is distributed.
Due to the characteristics of services versus products (services are intangible, vary across
providers, etc.), a typical consumer may have more difficulty evaluating the relative quality of a
service when compared to a tangible product; unlike marketing a specific medication, creating a
magazine advertisement for an abstract therapeutic approach like CBT proves to be more
difficult. Zeithaml, Bitner, and Gremler (2012) argue that this is why word-of-mouth
communication about services is often considered more credible than direct advertising. By its
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very nature, therapy is a service that requires the customer to experience it to determine its value,
suggesting that any efforts to increase the dissemination of EBPIs may consider incorporation of
word-of-mouth endorsements as a critical source of influence.
Deciding on where to place DTC marketing materials is critically important for reaching
both health care providers and consumers as a means to engender discussion of treatment
options. In addition, the importance of first-hand accounts of specific services suggests that
consumers look for personal testimony in making decisions about somewhat intangible products.
Individuals increasingly report using the Internet as their primary source of information for
health-related questions, commonly using general search engines to find answers to their
questions (Morahan-Martin, 2004). The Internet has quickly become the first place individuals
begin their search for health-related questions, although the accuracy and value of this type of
information is often suspect (Hesse, et al., 2005).
In addition, place refers to the actual location in which services are delivered. Time- and
cost-related issues are increasingly moving many health services out of traditional office-based
settings, as technology-assisted interventions continue to gain evidence based support (Kazdin &
Blase, 2011). A specific area for this expansion of service delivery is the Internet. Several metaanalyses of the efficacy of Internet-delivered cognitive behavior therapy demonstrated the
benefits of this type of approach, showing similar effectiveness to face-to-face CBT when
coupled with resources and therapist support (Andersson & Cuijpers, 2009; Andrews, Cuijpers,
Craske, McEvoy, & Titov, 2010). The unique nature of psychotherapy as a service makes it
potentially well-suited to take advantage of this aspect of marketing, giving it a competitive
advantage over the DTC marketing efforts of the pharmaceutical industry.
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Promotion. The most well-known and commonly associated component of the marketing
mix involves the active process of communicating information to the consumer. How promotion
occurs relies heavily on the previously discussed components, such as the service attributes
defined by the product itself, the availability and related costs, and the channels through which
the information is distributed. Particularly important is establishing the competitive advantage of
a particular product or service when compared to alternatives. The pharmaceutical industry has
an excellent track record of using these types of promotional strategies known as “positioning
statements,” a concise description of the target market as well as a portrayal of how that market
should perceive the brand (Stayman, 2013). Examples of this include early advertisements for
Zoloft referring to it as “the number one prescribed drug of its kind” or Ambien’s claim of a
unique two-layer system that allows the consumer to stay asleep longer than other sleep aids
(Becker, 2015). While these statements do not necessarily provide the consumer with a great deal
of specific evidentiary knowledge, they clearly provide a distinction between the product being
advertised and other, seemingly less desirable alternatives.
Perhaps the most important part of the promotional aspect of marketing is the ability to
relate to the consumer successfully. This feature involves using language that is comprehensible,
appealing, and clear, with the ultimate goal of resonating with a specific target group. Although
psychology as a field has been somewhat ineffective implementing this component of marketing
with respect to research findings, there are models in place that are not being utilized effectively.
The Centers for Disease Control and Prevention (CDC) provided health care providers with a set
of guidelines to help translate complicated, scientific information into a concise, palatable, and
meaningful message for the target consumer (Centers for Disease Control and Prevention, 2009).
While some health care agencies have understood the importance of this type of promotion, the
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realm of clinical psychology has embraced it less successfully. Even though resources exist to
help explain some of the concepts behind EBPIs, Becker (2015) found that a majority of
respondents indicated confusion and negative opinions when surveyed about their reactions to
information about “evidence-based” mental health treatments.
Finally, promotion of a product involves specific appeals to consumer interests. Current
DTC advertisements of pharmaceutical products provide some clues to understanding how
consumers respond to these various types of marketing appeals. Because they are regulated by
the FDA and are almost always product-focused, these ads are required to include a certain
amount of factual information and therefore rely on a rational-type approach. However, findings
from several examinations of the types of appeals used in prescription drug advertisements
indicate that almost all include some emotional appeal component as well (Pinto, 2000). Macias,
Pashupati, and Lewis (2007) reviewed television and print ads from pharmaceutical companies
and found that rational and emotional appeals were used in a similar fashion, although print ads
were found to have more drug information than TV ads. This feature of text-based ads suggests it
as a more appropriate medium for disseminating information about mental health services; given
the public’s limited knowledge about EBPIs, providing information via printed, Internet-based
sources may be essential to market treatment for psychological disorders.
Marketing psychological services
The body of evidence surrounding dissemination and diffusion of knowledge about
psychological treatments points to a deficit in efforts to incorporate consumers and leverage
existing methods of demonstrably effective marketing techniques. Not only are most individuals
unaware of what types of treatments are effective, those who do have some information that
allows them to discern differences between treatment approaches are frequently unaware of the
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best way to access these services. Additionally, little has been done by researchers to understand
how to communicate this information more effectively to actual consumers. As such, an
investigation of the basic strategies for informing, motivating, and influencing consumer
behavior in the realm of psychological treatments is necessary to advance work in this area. The
next step in this line of research is to examine the effect of DTC advertising on people’s attitudes
toward, willingness to engage in, and overall knowledge cognitive-behavioral therapy (CBT) for
the treatment of anxiety disorders.
As little has been done to examine the effects of marketing of psychotherapy treatments,
all experimental stimuli for engaging consumer interest were developed based on general
principles of advertising. A generally accepted model for advertising appeals posits that they are
either primarily emotional or rational in nature (Laskey et al., 1995). Emotional appeals attempt
to elicit a response in the consumer to generate interest in the product or service, while rational
appeals seek to provide information about why the product or service is necessary or important.
Most advertisements use a combination of these types of appeals (Albers-Mill & Stafford, 1999),
and neither approach has been demonstrated to be unambiguously more effective than the other.
In an analysis of commonalities among advertisements for services in the United Kingdom,
Mortimer (2008) found that emotional appeals were generally more successful regardless of the
type of service being advertised; on the contrary, a study on attitudes surrounding various
advertisements across types of media indicated that rational appeals generated more positive
responses overall (Stafford & Day, 1995). How these findings apply to advertisements of EBPIs
remains to be seen.
Additionally, advertising research has distinguished between directive and non-directive
messages. Directive messages encourage individuals to take specific action (e.g., “If you are
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suffering, get help today”), whereas non-directive messages simply provide general information
about available products. In their analysis of DTC marketing of pharmaceutical products, Tsai
and Lancaster (2012) found that directive advertisements that mention product names related to
specific medical conditions and encourage the consumer to seek these out from their doctors are
the most effective form of raising awareness about a particular product. Less directive types of
DTC advertisements have been rated as less appealing and can confuse the consumer (Sheehan,
2003). Conversely, Hadley (1953) examined trends in advertisements for products such as beer
and cigarettes and noted that inferred or non-directive techniques are particularly effective in
allowing the consumer to feel as though he/she is making a decision independently without being
told what to purchase. Later research on consumer choice has corroborated the idea that for some
goods and services, autonomy and freedom play an important role in motivating individual
behavior (e.g., Ackerberg, 2003; Friedmann & Zimmer, 2013; Richins, 1995). However, this
area of variability in advertising appeals has been relatively ignored with respect to treatment for
health-related services, despite the importance of consumer motivations for seeking services
(Coles & Coleman, 2010).
The means by which psychological treatments are marketed is especially important for
greater dissemination and diffusion about EBPIs. The Internet offers a particularly adaptable and
mass-market tool for this end. According to the United States Census (2013), 75% of individuals
have Internet access, representing a monumental change from the 19% reported in 2003 (File &
Ryan, 2014). Furthermore, evidence suggests the Internet is not only the primary source of
information about health care needs, but it also greatly influences consumer knowledge and
behavior. Murray and colleagues (2003) found that 85% of surveyed physicians reported that
their patients have brought information from the Internet in during a visit. Web-based
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advertisements have also been demonstrated to influence consumer behavior. Choi & Lee
(2007), for example, found that study participants were receptive to the Web as a source of
prescription drug information. When assessed in comparison to traditional media, study
respondents rated information advertised via the Web as the most credible source of prescription
drug information. This finding was significantly different from earlier studies that demonstrated
that individuals found Web-based information as less credible than other various media sources
(e.g., Huh, DeLorne, & Reid, 2004). As the world of advertising continues to grow and change
towards a focus on internet-based resources, research concerning the effectiveness of utilizing
these techniques to reach consumers of therapy services needs to be done in order to understand
how to disseminate effectively knowledge and information about anxiety disorders and
associated treatments. The current study explores the notion that the Internet can also aid in this
process, reducing the burden on the consumer while providing a wealth of information at little to
no cost.
Developing the Commercial Stimuli
The dominant model in marketing with respect to appeals distinguishes between rational
and emotional content as a way to influence consumer behavior (Albers-Miller & Stafford,
1999). The current study emphasized different stimuli on this basis, constructing several forms of
advertisement that fundamentally differ in terms of their appeal to either emotion or reason. To
represent the rational appeal, a didactic explanation about the nature of anxiety disorders and
associated treatment conveyed an assumed expert’s knowledge about exposure therapy. For the
emotional appeal, a first-person account was created in the style of an individual's testimonial
response to the same type of therapy. The content of the marketing materials used for the study
was derived from the empirically identified important components of marketing as outlined
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above, including the primary features of the marketing mix as well as directive and non-directive
messages (i.e., Becker, 2015; Johar & Sirgy, 1991; Porter & Golan, 2006). Each advertisement
was presented in multiple modalities, in this case written text and video.
The two types of advertising appeals were constructed using the most frequently cited
elements of marketing from traditional advertising research. Each message was designed to
contain parallel information about the service itself (i.e., the product - CBT techniques for
anxiety), the cost of services (i.e., price, such as insurance coverage, typical treatment duration,
etc.), and where to receive those services (i.e., place, such as a website to locate treatment
providers). In addition, the two types of appeals were designed to have easily distinguishable
positioning statements to discriminate between the promotional aspects of each. The emotional
appeal placed an emphasis on the individual consumer’s experience with the service (i.e., a
personal testimonial about how effective the service was at treating his/her anxiety), whereas the
rational appeal presented factual information about the service based on findings from marketing
research (e.g., Zeithaml, Bitner, & Gremler, 2012).
In addition, a second independent variable was included to vary the concluding message
of the appeals. This variable was comprised of two levels (directive and non-directive), and was
fully crossed with both appeal types (emotional and rational). Thus, eight different stimuli were
developed: four distinct appeal types based on the two independent variables above (emotionaldirect; emotional-indirect; rational-direct; and rational-indirect), each of which was depicted in
one of two formats (text-based descriptions; videos that verbalize identical scripts). The tone of
groups containing directive statements was such that active engagement with the service (CBT)
is recommended. Accordingly, the tone of non-directive groups contained reference to facts,
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opinions, or individual outcomes without emphasis on what the reader should do as a result. See
Appendix B for the full commercial scripts.
Further, the emotional appeal was constructed to convey an individual perspective,
emphasizing testimonial (i.e., anecdotal) information. It focused on factors seen commonly in
DTC advertising of pharmaceutical products, such as highlighting individual subjective distress,
a desire to “return to normal,” and the nurturing component of therapy (as derived from content
analysis of typical DTC advertisements for pharmaceutical products; Mortimer, 2008). Rational
appeals were presented from the perspective of an expert, with a tone that is more general in
nature and references information from a broader array of sources (e.g., treatment outcome
literature). For the video format, the same nonspecific video was shown, and the script was
varied to isolate the differences of the appeal type.
Present Study
The present study examined how potential consumers of mental health services respond
to Internet-based marketing information about EBPIs. Since the general consensus from the
literature is somewhat inconclusive, the current study aimed to provide a more nuanced approach
to understanding consumer reactions to stylistically dichotomized advertisements. In an effort to
provide greater clarity regarding how these factors influence effective DTC advertising for
psychological treatments, the current study assessed participant reactions to examples of the two
most commonly used advertising appeals through a realistic (albeit controlled analogue) online
marketing campaign. Consolidating previous literature, this demands that marketing stimuli
provide information about the types of issues commonly seen related to anxiety disorders, what
types of treatments are available, and the best ways to go about seeking those services. The
hypotheses examined were as follows:
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1. When comparing emotional and informational/rational appeals, consumers will
respond more favorably to messages emphasizing emotional appeals that contain
first-hand accounts of EBPI descriptions (i.e., anecdotes or testimonials) than to
informational/rational appeals.
a. Consumers will attend to and rate more favorably emotional appeals that
contain first-hand accounts of EBPI descriptions when the tone of the message
is persuasive and directive.
b. Consumers will be more likely to report intent on seeking or recommending
services after viewing emotional appeals that contain first-hand accounts of
EBPI descriptions when the tone of the message is persuasive and directive.
2. Consumers will be able to recall information about emotional appeals more
effectively than informational appeals.
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II. METHOD
Participants
Students enrolled in introductory level college psychology courses were given the
opportunity to participate in the current study. Participants were enlisted via the online research
credit website used by the psychology department for study recruitment. After completing a
consent form and verifying their age, participants filled out demographic questions and
completed the DASS-21 before being shown one of the eight random experimental stimuli:
either a text or video advertisement with one of four types of appeal (emotional directive,
emotional nondirective, rational directive, or rational nondirective). Of the initial respondents
(N=1032), 931 fully completed the survey. Of those who completely finished, the data was
evaluated for accuracy and validity, using the recall questions as a quality check. 325
respondents missed at least one of the recall questions and were removed from the final analysis
to reduce the chance of confounding the results.
The final sample consisted of 606 students (mean age = 18.81, SD = 1.33) at time one,
who were randomly assigned to conditions. The numbers of participants by condition were
approximately equivalent between the video (N=289) and text (N=317) advertisements. The
number of participants in each group was not significantly different: 80 (13.2%) Emotional
Directive video; 72 (11.9%) Emotional Nondirective video; 67 (11.1%) Rational Directive video;
70 (11.6%) Rational Nondirective video; 74 (12.2%) Emotional Directive text; 88 (14.5%)
Emotional Nondirective text; 81 (13.4%) Rational Directive text; and 74 (12.2%) Rational
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Nondirective text. The sample was primarily female (68.5%) and Caucasian (82.3%). Sample
characteristics are displayed in Table 1.

Measures
Anxiety ratings. All participants completed the 21-item Depression, Anxiety, and Stress
Scale. The Depression, Anxiety, and Stress Scale (DASS-21) is a frequently used measure of
depression and anxiety that contains three, 7-item scales measuring depression, anxiety, and
stress (Antony et al., 1998; Lovibond & Lovibond, 1995). Scores for the DASS-21 are
calculated by summing each respective scale and multiplying by two, with scores for each
individual scale ranging from 0 to 42 and higher scores indicating greater perceived levels of
depression, anxiety and stress. This measure utilizes cutoff scores to determine levels of severity
of symptom distress (Antony et al., 1998). The anxiety subscale, the primary subscale of interest
for the present study, has shown adequate reliability in previous studies (α 1 = .78 to .90). See
Appendix C for the full measure. With regards to anxiety subscale scores, there were no
significant differences between any groups in the study.
Advertisement Evaluation. The effectiveness of an advertisement is often measured in
terms of consumer attitudes and opinions (MacKenzie, Lutz, & Belch, 1986), which are
themselves demonstrable components of product or service adoption decisions (Rogers, 2003). A
scale commonly used in marketing research to measure consumer attitudes was developed by
Madden, Allen, and Twible (1988), and it assesses fourteen dimensions of emotional response on
a 7-point Likert-type scale. This scale has a three-factor structure comprising positive affect,
negative affect, and evaluation, and each subscale has been shown to have adequate reliability (α
= .89, .75, .88, respectively; Madden, Allen, & Twible, 1988). Each of these subscales has been
demonstrated to play a role in consumer responses to marketing materials; affective reactions
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have been shown as a key indicator in previous research (Lutz, 1985; MacKenzie, Lutz, & Belch,
1986), as have content-based evaluations in traditional advertising (Brown & Stayman, 1992).
Additionally, several meta-analyses have demonstrated the moderating effects of affective and
cognitive reactions to consumers’ responses to advertising reflected by this measure (Brown,
Homer, & Inman, 1998; Muehling & McCann, 1993). Participants completed this scale
immediately after viewing their respective marketing materials. See Appendix C for the full
measure.
Intent to Try/Recommend. Given the importance of subjective experience and word-ofmouth referrals for the dissemination of experiential services like EBPIs, the current study also
sought to ascertain how likely potential consumers are to engage in or to recommend the types of
treatments being described. Spears and Singh (2004) developed a psychometrically sound
measure to assess both attitude toward the brand (Ab) and purchase intention (PI) (Ab α = .94
and PI α = .97; Spears & Singh, 2004), based on theory that suggests attitudes formed in
response to marketing materials motivate consumer behavior. This 10-item scale was given to
participants immediately after exposure to the appeals, although some language of the original
measure was modified to fit the context of the study (i.e., adding in specifiers about the type of
treatment described—“Describe your overall feelings about CBT for anxiety treatment.”).
Respondents were also be asked to imagine that he/she is suffering from an anxiety disorder and
then rate the likelihood that he/she would try the discussed treatment, as well as the likelihood of
recommending CBT to a friend or loved one with anxious symptoms. See Appendix C for the
full measure.
Recall. Three multiple-choice questions concerning the content of the advertisement (and
created specifically for this study were used to assess participants’ recall of the marketing stimuli
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at the beginning of data collection, as well as at time two. The questions assessed common
elements of each advertisement (e.g., “What mental health problem did the advertisement focus
on?”), so participants were asked the same questions regardless of the group to which they were
assigned. These questions served as a measure of how effectively participants attended to stimuli
and served as the primary validity check for the study. In addition, during follow-up, participants
were asked to indicate if they sought or recommended any of these types of services as a
qualitative measure of behavior. See Appendix C for these measures.
Procedure
After the study received approval from the University’s Institutional Review Board
(IRB), participants were recruited via the psychology department’s research website, SONA
System. The entire study was completed through an online survey site (Qualtrics). Participants
were assigned to one commercial condition (i.e., appeal type) via a randomizer. After obtaining
informed consent, participants completed a demographic questionnaire and the DASS-21 prior to
viewing the experimental materials. Immediately after viewing the commercial, participants
completed all advertisement-related measures. Participants were given research credit for their
participation after completing the measures at time one. Those interested in participating in the
follow-up survey were given an opportunity to provide their email address to be contacted within
two months of their original participation date. Consenting participants were contacted between
six and eight weeks after their initial participation (due to a holiday break at the university, there
was some variation in the time follow-up emails were sent out) with an email linking them to
follow-up measures to be completed via an online questionnaire (administered through
Qualtrics).
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Once all data were refined, multiple analyses of variance (ANOVAs) were performed to
investigate the main hypotheses in terms of group differences in dependent measures at time one.
In the event of a significant F test, follow-up t tests were conducted to determine specific group
discrepancies using Tukey’s honestly significant difference (HSD). All of the outcome measures
administered at data collection time one were examined separately, including: positive affective
response, negative affective response, advertisement content evaluation, intent to try, intent to
recommend, and recall. In addition, commercial conditions were analyzed for differences
between both media type (video vs text) and appeal type (rational vs emotional, directive vs
nondirective) using independent sample t tests. Finally, the data collected from those who
responded to the one-month follow-up email were insufficient to determine which randomly
assigned group displayed the greatest change over time, so analyses focus primarily on group
differences at the initial viewing of commercial stimuli.
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III. RESULTS
Data Screening
After data collection was complete, the information collected via electronic database was
screened for errors and incomplete/missing information. From the total pool of responses
(N=1032), surveys that were incomplete (Progress < 100%) were first excluded (n=101). Of
those responses that remained (n=931), the three recall questions were evaluated as a validity
check. Surveys that responded incorrectly to any one of those questions were removed (n=325),
resulting in 606 completed surveys that were included in the final analysis.
The Effect of Commercial Condition on Recall
Analysis of recall questions revealed that the majority of participants measured at time
one missed none of the questions assessing this construct. Therefore, recall was coded into a
categorical variable into two groups: those who answered all of the questions correctly (N = 606)
and those who missed one or more questions (N =325). Binary logistic regression was used to
assess the impact of commercial condition on the likelihood that viewers would answer all of the
questions correctly. The full model was not statistically significant (χ2 (7, N = 931) = 7.656, p =
.364), indicating that commercial condition did not predict viewers’ ability to recall details of the
commercial they viewed.
Group Differences
One-way analyses of variance (ANOVA) were performed to investigate group
differences in dependent measures. The independent variable was commercial condition, which
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consisted of eight different groups: Emotional Directive video, Emotional Nondirective video,
Rational Directive video, Rational Nondirective video, Rational Nondirective text, Rational
Directive text, Emotional Nondirective text, and Emotional Directive text advertisements. Each
outcome measure administered to participants was entered into its own ANOVA as the
dependent variable, including: Attitude toward Brand, Advertisement Evaluation, Intent to try
CBT, and Intent to recommend CBT. These analyses were repeated with the anxiety subscale
score from the DASS-21 entered as a covariate to determine if the individual respondent’s level
of symptomology had any statistical effect on outcome data. Table 2 contains means and
standard deviations for DASS-21anxiety scores by group.
Attitude to Brand and Advertisement Evaluation
Attitude to brand and advertisement evaluation were calculated by summing individual
items from the respective measures into one of three factors, positive affective response, negative
affective response, and advertisement evaluation. A one-way ANOVA was computed for each of
these three factors, with group membership as the factor: analyses of positive affective response
(F(7,582) = 1.67, p = .11), negative affective response (F(7,589) = .81, p = .58), and
advertisement evaluation F(7,598) = .78, p = .61) demonstrated no significant differences. See
Table 3 for full results.

Intent to Try/Recommend CBT
An overall sum was tabulated from questions for respondents’ intent to try CBT.
Significant group differences were demonstrated using a one-way ANOVA (F(7,598) = 2.50, p =
.02). A Tukey HSD post hoc test indicated that individuals in the Rational Directive video group
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were significantly less likely than those in the Rational Directive text video group to indicate a
strong intent to try CBT (p = .04, d = .20).
With respect to recommending CBT to others, respondent scores did not differ
significantly among groups as calculated by a one-way ANOVA (F(7,598) = .54, p = .81) when
analyzed using a summed total of scores related to these questions. See Table 4 for full results.
Comparing binary conditions
Independent sample t tests were conducted to compare commercial conditions using five
separate dependent measures: positive affective response, negative affective response,
advertisement evaluation, overall intent to try, and overall intent to recommend. These dependent
measures were evaluated grouped by condition type: video versus text and emotional appeal
versus rational appeal. When comparing dependent measures as a condition of video versus text
advertisement group, no significant results were demonstrated on any measure.
When comparing dependent measures as a condition of emotional appeal versus rational
appeal groups, a significant difference was found between emotional appeal advertisements and
rational appeal advertisements on the positive affective response measure (t(588) = 2.33, p = .02,
d = 0.19). Participants were significantly more likely to describe a positive affective response to
Emotional appeal advertisements (M = 13.75, SD = 6.40) than Rational appeal advertisements
(M = 12.55, SD = 5.96).
Independent sample t tests comparing directive versus nondirective approaches across
dependent measures produced a similar finding: namely, that positive affective response was
significantly different between directive versus nondirective conditions (t(588) = 2.05, p = .04, d
= 0.17). Participants were significantly more likely to describe a positive affective response to
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Directive appeal advertisements (M = 13.69, SD = 6.21) than Nondirective appeal advertisements
(M = 12.65, SD = 6.19). See Table 5 for full results.
Anxiety as a covariate
The same one-way analyses of variance on all dependent measures were computed with
anxiety entered in as a covariate. The independent variable was commercial condition, with
outcome measures mentioned above entered as separate, unitary dependent variables, and the
total anxiety subscale score from the DASS-21 was entered as a covariate to determine if the
individual respondent’s level of symptomology had any statistical effect on outcome data. There
were no significant findings with respect to positive affective response (F(7,581) = 1.48, p =
.17), negative affective response (F(7,588) = .72, p = .66), or total evaluation (F(7,597) = .77, p
= .61). There was a statistically significant finding with respect to intent to try CBT (F(7,597) =
2.47, p = .02), but no significant difference with respect to intent to recommend CBT (F(7,597) =
.54, p = .81). Follow-up Tukey’s HSD post hoc tests demonstrated a significant difference
between individuals in the Rational Directive video group versus those in the Rational Directive
text video group with respect to intent to try CBT (p = .05).
In addition, analyses were conducted on respondents who indicated anxiety symptoms
above a mild level on the DASS-21 (Anxiety subscale score > 5; n=167, 27.6% of the final
sample). Individuals in these categories are significantly more likely to be impaired as a result of
their symptoms, which may make advertisements about treatments potentially more salient. The
same one-way ANCOVAs outlined above were computed with this sample, which yielded
significant results on two measures: positive affective response (F(7,153) = 2.27, p = .03) and
intent to try CBT (F(7,158) = 2.63, p = .01), but no other measures (negative affective response
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(F(7,158) = .48, p = .85); overall advertisement evaluation (F(7,158) = .995, p = .44); intent to
recommend CBT (F(7,158) = .596, p = .76)).
Follow-up analyses using Tukey’s HSD indicated several significant group differences.
In terms of positive affective response, individuals in the Emotional Directive video group rated
significantly higher than those in the Rational Directive video group (p = .01), as well as those in
Rational Nondirective text group (p = .01). Individuals in the Emotional Nondirective text group
rated positive affective response significantly higher than those in the Rational Directive video
group (p = .01) and those in the Rational Nondirective text group (p = .02). Individuals in the
Rational Directive text group were significantly higher than those in the Rational Nondirective
text group (p = .03). In terms of intent to try CBT, individuals in the Rational Directive video
group rated significantly lower than those in all other groups (compared to Rational Directive
video group p < .01, Emotional Nondirective video group p = .04, Rational Nondirective video
group p = .01, Emotional Directive text group p < .01, Emotional Nondirective text group p <
.01, Rational Directive text group p < .01, and Rational Nondirective text group p = .03). See
Table 6 for ANCOVA results.
Content analysis of respondents’ comments
In the current study, three of every ten respondents (n=190; 31.4%) provided personal
comments about the advertisements when completing study surveys. These comments were
examined qualitatively and subjected to content analysis, which ultimately coded each into one
of the following six overarching groups: 1) positive response to commercial; 2) critical
evaluation of commercial quality/production value; 3) informative value of commercial; 4)
desire for greater information after viewing commercial; 5) suggestions for improving the
commercial; and 6) other/miscellaneous comments not fitting into a single category. These

36

categories were derived using evaluative criteria derived from qualitative research guidelines,
especially methods of describing and explaining qualitative data (Miles, Huberman, & Saldana,
2014). Each comment was analyzed for categorical themes (e.g., adjectives used in descriptions)
and then clustered via an iterative sorting process. After determining the broad categories of
qualitative comments, each was coded into a primary category to provide frequency of thematic
responses. The majority (n=108; 56.8% of comments) indicated a positive response or feeling
about the commercial (e.g., “It was very interesting to read about this;” “The commercial was
nice.”), although a substantial percentage of respondents (n=37; 19.5% of comments) remarked
on the low production quality of commercials (e.g., “It’s a bit boring and the music is too
somber,” “The camera work was a little shaky,” “It felt too descriptive,” etc.). The next most
common category of substantive comments (n=14; 2.3%) included responses that provided
suggestions for improvement, such as, “I would have liked to see a convincing testimonial
included,” “A compare/contrast approach would be more successful,” “…would be more
interesting by giving shocking or interesting facts,” etc. These comments provide important
information from potential consumers about their expectations for and reactions to
advertisements for which they are the target audience.
Using these qualitatively derived categories to describe comments, a multinomial logistic
regression was used to assess the impact of commercial condition on whether individuals
responded with a particular type of comment. The full model was not statistically significant (χ2
(7, N = 191) = 30.76, p = .67), indicating that commercial condition did not predict whether
respondents would leave a personal comment. See Table 7 for full results.
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Follow-up survey data
Of those who completed the survey, 122 individuals indicated they would be interested in
providing follow-up data, which was collected between 4 and 8 weeks after the initial viewing of
the study. Of those, 22 (3.6% of the final sample) completed a follow-up survey which included
questions about recall, intent to try, and intent to recommend, as well as questions designed to
assess qualitative behavioral change about whether the individual sought or recommended CBT.
Though the limited response rate limits the comparison with the larger sample, the majority
(n=13; 59.1% of the follow-up sample) answered all recall questions correctly, and over a quarter
(n=6; 27.3%) reported qualitative behavioral change—either endorsing that they researched more
about CBT or recommended it to a friend or family member.

38

IV. DISCUSSION
Overall, there was no evidence to suggest that one particular appeal or media type was
clearly superior to another in terms of overall response to an advertisement. While some
statistically significant differences were demonstrated with respect to positive affective response
and intent to try CBT, these differences did not suggest a general pattern of advertising that is
most effective. Emotional, directive appeals may in some conditions be preferred for capturing
consumers’ attention or provoking a stronger response, but since no group differences were clear
on the basis of various combinations of appeal and media type, significant generalizations cannot
be made. What seems to be evident, though, is that some effort for direct-to-consumer
advertising does seem to have an impact on consumer thought processes. For example, overall
scores on all dependent measures approached their respective maximum values, suggesting that
any type of advertising was likely to have a more positive effect than no advertising whatsoever.
Without an actual control group to measure attitudes towards psychological treatments in the
absence of advertisements, however, the magnitude of this effect is hard to gauge.
The hypothesis (H1a) that participants would respond more favorably to the emotional
appeals in terms of attitude, evaluation, and recall was only partially supported. Overall, the
emotional appeal-focused commercials demonstrated significant differences when compared to
their rational counterparts in terms of positive affective response, although the size of this effect
was small. This finding suggests that stylistic considerations may weigh more heavily on
individual’s perceptions and evaluation than overall content, but the limited scope of this finding
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and the overall pattern of positive response to advertisements in general suggest that no single
approach to advertising can be classified as universally preferred.
The hypothesis (H1b) that participants would be more likely to report intent to try or
recommend based on appeal type was also partially supported by the results of the current study.
An overall significant difference among groups was demonstrated when participants were asked
to rate their intent to try CBT, although the effect size was small. Isolating specific appeal types
(e.g., directive versus nondirective, emotional versus rational) did not indicate a clearly superior
approach to advertising, even though certain combinations of these advertising strategies were
statistically more likely to generate positive endorsement from participants. Individuals in the
rational directive text group were more likely to report overall intent to try CBT than those in the
corresponding rational directive video group. These differences were not observed between other
groups, however, or when participants were asked their likelihood in recommending CBT as a
treatment to others. Thus, there was no evidence to suggest a specific appeal or media type was
more effective to this end.
The hypothesis (H2) predicting that participants would recall information more
effectively in emotional appeal conditions also lacked support in the current study. No evidence
was found to demonstrate that any condition had an impact on overall recall. The overall number
of participants who answered recall questions incorrectly (n=325, or 35% of those who
completed the initial survey) suggests a high rate of error; however, when compared to previous
studies on Internet-based advertising, these results are not surprising (e.g., Couper, 2000; Evans
& Mathur, 2005; Hewson & Stewart, 2016). In addition, given the error rates were not
statistically different among groups in the present study, it is likely that recall inaccuracies were
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due more to the inherent nature of online survey research rather than some inherent quality of the
advertising approach used.
Overall, however, the results from the study suggest that efforts to increase direct-toconsumer advertising of psychological treatments in a general sense may have positive effects on
individuals’ knowledge and interest in these services. The overall pattern of responses from all
groups indicated high scores on measures assessing attitude toward brand, likelihood to try, etc.
Although differences among group scores were somewhat limited, there were differences among
the various groups when considering only individuals who reported a moderate or higher level of
anxiety symptoms. The somewhat confusing pattern of differences make categorical conclusions
difficult, but these results suggest that those with more significant anxiety symptoms displayed
more significant differences terms of their response to advertising stimuli. Additional efforts to
increase consumer awareness about psychological treatments may be a useful approach for the
future of disseminating information about evidence-based interventions, especially to those most
in need of treatment.
While additional research investigating the relative advantages of various appeal and
media types is still needed, these preliminary results suggest the importance of developing directto-consumer advertisements for psychotherapeutic services. Future efforts may focus on refining
techniques to improve these consumer-based approaches. Specifically, individuals who
experience psychological symptoms may be more responsive to advertisements involving
appropriate treatments, a contention with at least some preliminary support given the results of
the current study.
The qualitative responses from participants also provided insight into the role direct-toconsumer advertising may play in future efforts. The most common type of feedback involved
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positive responses to the advertisement in general, suggesting that the subject matter of
advertising psychological treatment is novel. These included specific comments, such as:
“Thought it was a very nice informative commercial for a good cause/treatment option that
everyone should know about,” “The commercial was eye opening to alternative treatment instead
of taking medicine for anxiety,” “I've never heard of CBT! Great way to get information out
there.” The second most frequently identified type of comment related to the quality of
advertisements themselves. Participants noted the lack of aesthetic value of both video and text
advertisements, such as how elements of the video or text advertisements grabbed their attention
(e.g, “The advertisement could have more artistic flare to keep the watcher more engaged,”
“Boring to read if you have absolutely no interest in the subject,” “Pictures/videos would have
evoked more emotion,” “I felt the video was not engaging enough,” etc.). These types of
comments are useful in the development of more effective advertisements, and they suggest that
stylistic considerations are an important component for individual consumers of a product. The
third most frequent category of response involved suggestions for improving advertising efforts,
something that is commonly practiced in other domains of marketing. These types of comments
(e.g., “Could have been more motivating or targeted why it’s good to help,” “What are some of
the skills they do in therapy that can help an anxious person?”, “A student actually going through
with therapy, allowing the audience to have a visual idea of how therapy would go?”) provide
useful insight about the type of information consumers expect from advertisements for these
types of services. Taken together, the comments provided by respondents corroborate the
fundamental rationale for the current study—i.e., direct-to-consumer marketing for psychological
treatments is a useful area for research efforts—and provide suggestions for future revision of
efforts in this domain.
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Finally, the results of the present study suggest that the barriers to implementation of
effective direct-to-consumer advertising are more complex than finding one ideal mode of
presenting information to potential consumers. Media format, advertisement tone, stylistic
considerations, and appeal type influence different individuals in different ways, and no clear
pattern clearly emerged in terms of preferential advertising. However, the present study is useful
insofar as it begins to identify certain trends in consumer preferences with respect to advertising
psychological treatments. Study participants tended to have slightly more positive emotional
responses to advertisements in certain formats, which may be due to the nature of the media or
appeal type itself. Additionally, the data suggest that individual characteristics—especially the
respondent’s subjective report of anxiety symptoms—may also play a role in this evaluation. At
the broadest level, no clearly preferred method of presenting information to potential consumers
was evident. For example, an advertisement displaying people in various situations with
accompanying music may make for a more pleasing aesthetic experience than reading the same
information in text format. However, in the present study, some who saw advertisements in text
format were more likely to state they would try the treatment themselves, which may suggest that
some consumers prefer reading information in greater detail to generate personal interest in an
advertised product more successfully. The lack of any specific variable that impacts recall of
information in advertisements, however, makes categorical prescription of advertising strategies
difficult, but this finding is consistent with research in other areas (e.g., Goodrich, 2011).
The current study also fills an important need in current research by examining an area
that has been generally neglected by rigorous study in psychological science. While extensive
research on consumer preferences, attitudes, and behavior has been conducted around a variety
of products and services, psychological treatments have previously been largely ignored as a
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subject of advertising strategies (Gallo, Comer, & Barlow, 2013). This initial effort to elucidate
approaches that are most effective for advertising psychological treatment is important for future
research. Given the differential effects of attitudes and evaluation of advertisements on consumer
behavior, it is critical to understand which methods may have the greatest impact in developing
dissemination strategies of evidence-based psychological treatments (Santucci, McHugh, &
Barlow, 2012). If consumers are informed and knowledgeable about a range of treatment
options, they can be transformative in the ways mental health services are delivered. Addressing
the “treatment gap” or “unmet need” of possible mental health consumers that has been
identified (e.g., Demyttenaere et al., 2004; Kohn, Saxena, Levav, & Caraceno, 2004) may be a
critical step in improving overall dissemination of EBPIs. Prevailing understanding about the
adoption rate of diffusions indicates that impacting the way innovations are adopted and methods
implemented produces overall social system change (Rogers, 2003). Given the near-absent
efforts to impact these systems from a “bottom up” approach by directly targeting consumers, the
results from the current study suggest a different tactic may be useful.
The current study also provides an initial framework for future research that may evaluate
the best way to target specific demographics, such as those most likely to be interested in and
benefit from mental health treatment services. As demonstrated, individuals who experience
more anxiety symptoms than the general population were more like to respond positively to
various advertisements and to report that they would interested in trying CBT for their
symptoms. As demonstrated in other marketing campaigns, directly appealing to consumer
experience is a useful tact for generating interest in and demand for a particular product. The
high level of responsiveness to the advertisements, as well as specific qualitative comments from
respondents, suggests that individuals are interested in receiving information about products and
44

services that are often targeted to professional or academic settings. That the overwhelming
focus of dissemination research has been on addressing the research-practice gap belies the
importance of consumer attitudes towards EBPIs. As seen in the successful approaches used in
other fields (e.g., the pharmaceutical industry), the efforts to improve marketing efforts from
both a provider and consumer standpoint are critical for future endeavors in dissemination
research.
Limitations
There were several limitations with the current study that could be improved with future
efforts in this area. Most significantly, the lack of substantial follow-up data limits the
conclusions that can be drawn about how advertising psychological treatments may impact longterm consumer behavior. This limitation also inherently restricted the generalizability of the
effects demonstrated, since individual responses in a laboratory-based setting do not always
translate to substantive behavior change in more naturalistic environments. Additionally, the
current study lacked the resources typically used in marketing campaigns, thus creating an
imprecise representation of the types of advertisements generally seen by individuals in daily
life. The experimental stimuli were necessarily analogues for their real-world counterparts, and
how factors such as well resourced, professionally produced advertisements about psychological
treatments impact consumer attitudes remains to be seen. However, given the generally positive
responses to all commercials despite the lack of resources involved in their creation, the
suggestions from study participants are encouraging for future endeavors in developing more
sophisticated efforts to target directly consumers of mental health services. In fact, that a
considerable portion of respondents indicated concerns about the quality of the commercial
stimuli, but were still (overall) endorsing high levels of response, suggests the importance of
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further study in this area. More sophisticated advertisements may wish to incorporate higher
production values, more narrowly targeted information, or greater specificity with respect to
certain appeal types. For example, given the frequency of comments about personal testimonials
by study respondents, additional research efforts may wish to compare professionally produced
videos with more personal, homemade versions (e.g., YouTube video-style testimonials) to
ascertain differences in consumer responses to these various approaches.
The current study may have also benefited from measures specifically developed to
gauge consumer attitudes about psychological treatments; many other areas of marketing have
domain- or product-specific approaches to evaluate how their products are received by potential
consumers, but the lack of those types of measures in this area meant that existing tools had to be
adapted. A possible shortcoming of this approach is that it may necessarily fail to capture the
types of attitudes and beliefs that compel individuals to act with respect to seeking mental health
services, something that has been influenced by a variety of factors according to previous
research (e.g., Becker, 2015). Thus, the ceiling effects noted in the current study for many of the
dependent variables may not be directly predictive of actual in vivo behavior. In the context of
the current study, there were no measures that could be used to further refine data collection, but
future research efforts may wish to develop the types of tools necessary to differentiate more
nuanced attitudes potential consumers have about EBPIs. Similarly, appropriate measures that
can more accurately discriminate among consumer attitudes would be useful tools for further
research in this area.
Finally, the current study relied on data from college undergraduates, a sample that is
demographically different than the greater population that may be interested in mental health
treatment. It is possible that individuals with different levels of education, access to internet
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services, and exposure to mental health concepts may respond differently to the same stimuli. In
order to draw more general conclusions about the impact of advertising techniques, a more
robust and diverse sample may provide key insight into developing the most effective direct-toconsumer advertisements of psychological treatments. Although the population studied is already
among the most likely to seek psychological services, efforts have identified the importance of
specifically targeting certain demographics in terms of providing information about services to
increase utilization of treatment options, and other studies have demonstrated the effectiveness of
providing college students with information about mental health services in terms of increasing
utilization (e.g., Yorgason, Linville, & Zitzman, 2010; Hunt & Eisenberg, 2010).
Future Research
The limited research base in this area of direct-to-consumer marketing provides a wide
range of future possibilities for additional research. Additional manipulation of variables (e.g.,
different types of audio and visual cues, embedding advertisements in naturalistic contexts, etc.)
could provide greater insight into the impact this type of marketing has on consumer attitudes
and behaviors. Approaching the question from a marketing perspective also requires a substantial
evaluation of costs and benefits of advertising strategies in order to ascertain the balance between
investment in marketing and the payoff for providers of a service. These types of cost-benefit
analyses are necessarily beyond the scope of the current study, but they form a crucial
component of most advertising efforts. Expanding on the type of information conveyed,
including identifying which specific cues potential consumers respond to, which demographics
are most suitable for DTC efforts, and what other types of psychological symptoms predispose
individuals to be receptive to advertisements, would be an ideal next step in this area of research.
Developing studies in any of these areas of inquiry may improve understanding of the complex
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relationship between advertising strategies and consumer response in order to better understand
the real-world implications of dissemination efforts.
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Table 1. Sample Characteristics

Total N = 606
Age

M = 18.81, SD = 1.33

Gender
Female

415

(68.5%)

Male

190

(31.4%)

Other

1

(0.2%)

White

499

(82.3%)

Black or African American

65

(10.7%)

Hispanic or Latino

9

(1.5%)

Asian

19

(3.1%)

Other

14

(2.3%)

Freshman

439

(72.4%)

Sophomore

93

(15.3%)

Junior

41

(6.8%)

Senior

33

(5.4%)

Ethnicity

Class Standing

Commercial Conditions

Video Advertisement

Text Advertisement

Emotional Directive

80

(13.2%)

74

(12.2%)

Emotional Nondirective

72

(11.9%)

88

(14.5%)

Rational Directive

67

(11.1%)

81

(13.4%)

Rational Nondirective

70

(11.6%)

74

(12.2%)
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Table 2
Means and Standard Deviations of Anxiety Scores on the DASS-21
Condition
Emotional Directive Video
Emotional Nondirective Video
Rational Directive Video
Rational Nondirective Video
Emotional Directive Text
Emotional Nondirective Text
Rational Directive Text
Rational Nondirective Text

M
3.93
4.03
3.69
3.04
4.68
2.84
3.33
3.50

n
80
72
67
70
74
88
81
74

Note: N= 606; higher scores indicate higher anxiety symptoms
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SD
3.92
3.84
3.60
3.56
4.66
3.21
3.67
3.48

Table 3.1
Means and Standard Deviations on Attitude Toward Brand and Advertisement Evaluation
Positive Affective Response
Condition
Emotional Directive Video
Emotional Nondirective Video
Rational Directive Video
Rational Nondirective Video
Emotional Directive Text
Emotional Nondirective Text
Rational Directive Text
Rational Nondirective Text

n
77
71
67
66
73
86
80
70

M
14.44
13.17
12.75
12.48
14.04
13.35
13.45
11.41

SD
6.67
5.62
5.52
6.12
5.85
7.19
6.60
5.36

M
4.35
4.35
4.73
4.54
4.53
4.02
4.05
4.53

SD
2.46
2.56
2.76
2.56
2.39
2.35
1.94
2.21

M
25.88
24.54
26.10
26.52
26.58
25.22
25.10
25.18

SD
7.98
6.88
7.98
6.66
5.94
7.94
6.55
7.49

Note: N= 590; higher scores indicate more positive affective response

Negative Affective Response
Condition
Emotional Directive Video
Emotional Nondirective Video
Rational Directive Video
Rational Nondirective Video
Emotional Directive Text
Emotional Nondirective Text
Rational Directive Text
Rational Nondirective Text

n
79
72
66
69
73
86
80
72

Note: N= 597; higher scores indicate more negative affective response

Advertisement Evaluation
Condition
Emotional Directive Video
Emotional Nondirective Video
Rational Directive Video
Rational Nondirective Video
Emotional Directive Text
Emotional Nondirective Text
Rational Directive Text
Rational Nondirective Text

n
80
72
67
70
74
88
81
74

Note: N= 606; higher scores indicate more positive evaluation

69

Table 3.2
One-Way Analyses of Variance of Attitude Toward Brand and Advertisement Evaluation
Positive Affective Response
Source

Sum of Squares

Between
Groups

df

Mean Square

447.69

7

63.60

Within Groups

22313.33

582

38.34

Total

22761.02

589

F

p

1.67

.11

Negative Affective Response
Source

Sum of Squares

Between
Groups

df

Mean Square

32.68

7

4.67

Within Groups

3402.51

589

5.78

Total

3435.20

596

F

p

.81

.58

Advertisement Evaluation
Source
Between
Groups
Within Groups

Sum of Squares

df

Mean Square

280.98

7

40.14

31239.73

598

52.24

70

F

p

.77

.61

Total

31520.71

605
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Table 4.1
Means and Standard Deviations on Intent to Try and Intent to Recommend
Intent to Try CBT
Condition
Emotional Directive Video
Emotional Nondirective Video
Rational Directive Video*
Rational Nondirective Video
Emotional Directive Text
Emotional Nondirective Text
Rational Directive Text*
Rational Nondirective Text

n
80
72
67
70
74
88
81
74

M
23.10
20.97
19.82
22.80
23.71
21.69
23.83
21.26

SD
7.95
6.86
8.10
7.88
7.25
8.77
6.97
7.83

M
24.99
23.38
23.72
24.49
24.51
24.40
25.37
24.27

SD
7.49
6.95
8.19
8.03
6.81
8.31
6.58
7.74

Note: N= 606; higher scores indicate higher likelihood to try; *p < 0.05

Intent to Recommend CBT
Condition
Emotional Directive Video
Emotional Nondirective Video
Rational Directive Video
Rational Nondirective Video
Emotional Directive Text
Emotional Nondirective Text
Rational Directive Text
Rational Nondirective Text

n
80
72
67
70
74
88
81
74

Note: N= 606; higher scores indicate higher likelihood to recommend
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Table 4.2
One-Way Analyses of Variance of Intent to Try and Recommend CBT
Intent to Try CBT
Source

Sum of Squares

Between
Groups

df

Mean Square

1050.76

7

150.11

Within Groups

35849.65

598

59.95

Total

36900.41

605

F

p

2.50

.02*

Intent to Recommend CBT
Source
Between Groups

Sum of Squares

df

Mean Square

213.37

7

30.48

Within Groups

33948.01

598

56.77

Total

34161.38

605

73

F

p
.54

.81

Table 5.1
Means and Standard Deviations of Conditions by Appeal and Media Type
Condition

Negative
Affect
M(SD)
4.48 (2.57)
4.27 (2.23)

Advertisement
Evaluation
M(SD)
25.75 (7.41)
25.50 (7.05)

Intent to Try
M(SD)

Video
Text

Positive
Affect
M(SD)
13.26 (6.03)
13.10 (6.39)

21.74 (7.79)
22.61 (7.82)

Intent to
Recommend
M(SD)
24.17 (7.65)
24.64 (7.40)

Emotional
Rational

13.75 (6.40)*
12.55 (5.96)*

4.30 (2.43)
4.44 (2.37)

25.55 (7.29)
25.69 (7.16)

22.36 (7.84)
22.01 (7.79)

24.34 (7.44)
24.50 (7.60)

Directive
Nondirective

13.69 (6.21)*
12.65 (6.19)*

4.40 (2.39)
4.34 (2.41)

25.89 (7.14)
25.35 (7.30)

22.72 (7.69)
21.67 (7.90)

24.69 (7.25)
24.14 (7.77)

*p < .05
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Table 5.2
Independent Samples t Tests of Conditions by Appeal and Media Type
Video vs. Text
Measure

F

Sig.

t

df

Positive affect
Negative affect
Evaluation
Intent to Try
Intent to
Recommend

.07
5.39
1.94
.01
.32

.79
.02
.16
.91
.57

.30
1.09
.44
-1.37
-.77

588
595
604
604
604

Sig. (twotailed)
.76
.27
.66
.17
.44

Emotional vs. Rational Appeal
Measure

F

Sig.

t

df

Positive affect
Negative affect
Evaluation
Intent to Try
Intent to
Recommend

1.75
.40
.10
.01
.08

.19
.53
.75
.94
.78

2.33
-.71
-.23
.56
-.26

588
595
604
604
604

Sig. (twotailed)
.02*
.48
.82
.58
.80

*p < .05

Directive vs. Nondirective Appeal
Measure

F

Sig.

t

df

Positive affect
Negative affect
Evaluation
Intent to Try
Intent to
Recommend

.05
.06
.19
.21
.97

.82
.81
.67
.65
.33

2.05
.30
.92
1.65
.90

588
595
604
604
604

*p < .05
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Sig. (twotailed)
.04*
.77
.36
.10
.37

Table 6.1
Adjusted Means and Standard Deviations on Dependent Measures with Total DASS-21 Anxiety
Score as a Covariate
Positive Affective Response
Condition
Emotional Directive Video
Emotional Nondirective Video
Rational Directive Video
Rational Nondirective Video
Emotional Directive Text
Emotional Nondirective Text
Rational Directive Text
Rational Nondirective Text

n
77
71
67
66
73
86
80
70

M
14.34
13.10
12.73
12.62
13.78
13.54
13.51
11.47

SE
.70
.73
.75
.76
.72
.66
.69
.73

M
4.33
4.32
4.72
4.57
4.47
4.07
4.07
4.53

SE
.27
.28
.30
.29
.28
.26
.27
.28

M
25.88
24.55
26.11
26.52
26.60
25.22
25.10
25.17

SE
.81
.85
.88
.87
.85
.77
.80
.84

Note: N= 590; higher scores indicate more positive affective response

Negative Affective Response
Condition
Emotional Directive Video
Emotional Nondirective Video
Rational Directive Video
Rational Nondirective Video
Emotional Directive Text
Emotional Nondirective Text
Rational Directive Text
Rational Nondirective Text

n
79
72
66
69
73
86
80
72

Note: N= 597; higher scores indicate more negative affective response

Advertisement Evaluation
Condition
Emotional Directive Video
Emotional Nondirective Video
Rational Directive Video
Rational Nondirective Video
Emotional Directive Text
Emotional Nondirective Text
Rational Directive Text
Rational Nondirective Text

n
80
72
67
70
74
88
81
74

Note: N= 606; higher scores indicate more positive evaluation
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Intent to Try CBT
Condition
Emotional Directive Video
Emotional Nondirective Video
Rational Directive Video*
Rational Nondirective Video
Emotional Directive Text
Emotional Nondirective Text
Rational Directive Text*
Rational Nondirective Text

n
80
72
67
70
74
88
81
74

M
23.06
20.92
19.81
22.87
23.60
21.78
23.86
21.27

SE
.87
.91
.95
.93
.90
.83
.86
.90

M
24.99
23.37
23.72
24.49
24.51
24.40
25.37
24.27

SE
.84
.89
.92
.90
.88
.81
.84
.88

Note: N= 606; higher scores indicate higher likelihood to try; *p < 0.05

Intent to Recommend CBT
Condition
Emotional Directive Video
Emotional Nondirective Video
Rational Directive Video
Rational Nondirective Video
Emotional Directive Text
Emotional Nondirective Text
Rational Directive Text
Rational Nondirective Text

n
80
72
67
70
74
88
81
74

Note: N= 606; higher scores indicate higher likelihood to recommend
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Table 6.2
One-Way Analyses of Variance on Dependent Measures with Total DASS-21 Anxiety Score as a
Covariate
Positive Affective Response
Source
Anxiety Score
Group
Error

Sum of Squares
524.87
388.30
21788.46

df
1
7
581

Mean Square
524.87
55.47
37.50

13.40
1.48

Partial Eta
Squared
.02
.02

6.36
.72

Partial Eta
Squared
.01
.01

.03
.77

Partial Eta
Squared
.00
.01

1.91
2.47*

Partial Eta
Squared
.00
.03

F

Negative Affective Response

Source
Anxiety Score
Group
Error

Sum of Squares
36.39
28.65
3366.12

df
1
7
588

Mean Square
36.39
4.09
5.73

F

Advertisement Evaluation

Source
Anxiety Score
Group
Error

Sum of Squares
1.44
282.10
31238.29

df
1
7
597

Mean Square
1.44
40.30
52.33

F

Intent to Try CBT

Source
Anxiety Score
Group
Error

Sum of Squares
114.40
1035.54
35735.26

df
1
7
597

Mean Square
114.40
147.93
59.86

F

*p < .05

Intent to Recommend CBT

Source
Anxiety Score
Group
Error

Sum of Squares
.13
213.49
33947.88

df
1
7
597
78

Mean Square
.13
30.50
56.86

F
.00
.54

Partial Eta
Squared
.00
.01

Table 6.3
Adjusted Means and Standard Deviations on Dependent Measures with Moderate-or-Greater
Anxiety Symptoms (DASS-21 Anxiety Score >5) as a Covariate
Positive Affective Response
Condition
Emotional Directive Video
Emotional Nondirective Video
Rational Directive Video
Rational Nondirective Video
Emotional Directive Text
Emotional Nondirective Text
Rational Directive Text
Rational Nondirective Text

n
20
19
19
17
28
19
21
19

M
16.37
13.28
10.92
14.51
14.35
16.13
15.62
11.37

SE
1.36
1.39
1.39
1.47
1.15
1.39
1.32
1.39

M
4.88
4.37
4.81
5.60
4.93
5.22
4.64
5.33

SE
.66
.65
.67
.69
.54
.67
.64
.64

M
26.10
24.48
23.63
26.86
27.15
27.08
25.47
22.82

SE
1.71
1.71
1.75
1.80
1.42
1.76
1.66
1.67

Note: N= 162; higher scores indicate more positive affective response

Negative Affective Response
Condition
Emotional Directive Video
Emotional Nondirective Video
Rational Directive Video
Rational Nondirective Video
Emotional Directive Text
Emotional Nondirective Text
Rational Directive Text
Rational Nondirective Text

n
20
20
19
18
29
19
21
21

Note: N= 167; higher scores indicate more negative affective response

Advertisement Evaluation
Condition
Emotional Directive Video
Emotional Nondirective Video
Rational Directive Video
Rational Nondirective Video
Emotional Directive Text
Emotional Nondirective Text
Rational Directive Text
Rational Nondirective Text

n
20
20
19
18
29
19
21
21

Note: N= 167; higher scores indicate more positive evaluation
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Intent to Try CBT
Condition
Emotional Directive Video
Emotional Nondirective Video
Rational Directive Video
Rational Nondirective Video
Emotional Directive Text
Emotional Nondirective Text
Rational Directive Text
Rational Nondirective Text

n
20
20
19
18
29
19
21
21

M
23.54
21.14
16.18
22.49
23.87
23.27
24.92
21.30

SE
1.67
1.66
1.70
1.75
1.39
1.71
1.62
1.62

M
24.35
23.16
21.11
23.07
23.43
24.81
25.67
24.03

SE
1.77
1.76
1.81
1.86
1.47
1.81
1.72
1.72

Note: N= 167; higher scores indicate higher likelihood to try

Intent to Recommend CBT
Condition
Emotional Directive Video
Emotional Nondirective Video
Rational Directive Video
Rational Nondirective Video
Emotional Directive Text
Emotional Nondirective Text
Rational Directive Text
Rational Nondirective Text

n
20
20
19
18
29
19
21
21

Note: N= 167; higher scores indicate higher likelihood to recommend

80

Table 6.4
One-Way Analyses of Variance on Dependent Measures with Moderate-or-Greater Anxiety
Symptoms (DASS-21 Anxiety Score > 5) as a Covariate
Positive Affective Response
Source
Anxiety Score
Group
Error

Sum of Squares
225.75
577.36
5572.38

df
1
7
153

Mean Square
225.75
82.48
36.42

F
6.20
2.27*

Partial Eta
Squared
.04
.09

*p < .05

Negative Affective Response

Source
Anxiety Score
Group
Error

Sum of Squares
6.81
28.31
1337.48

df
1
7
158

Mean Square
6.81
4.04
8.47

6.36
.72

Partial Eta
Squared
.01
.01

.59
1.00

Partial Eta
Squared
.00
.04

11.99
2.63*

Partial Eta
Squared
.07
.10

F

Advertisement Evaluation

Source
Anxiety Score
Group
Error

Sum of Squares
34.18
404.17
9168.43

df
1
7
158

Mean Square
34.18
57.74
58.03

F

Intent to Try CBT

Source
Anxiety Score
Group
Error

Sum of Squares
659.56
1011.04
8693.63

df
1
7
158

Mean Square
659.56
144.34
55.02

F

*p < .05

Intent to Recommend CBT

Source
Anxiety Score
Group
Error

Sum of Squares
.13
213.49
33947.88

df
1
7
597
81

Mean Square
.13
30.50

F
.00
.54

Partial Eta
Squared
.00
.01

Table 7
Frequencies of Qualitative Comments by Category
Category

108
37

%
Comments
56.8
19.5

%
Total
17.8
6.1

9
7
14
15

4.7
3.7
7.4
7.9

1.5
1.2
2.3
2.5

n

Positive Response to Commercial
Critical Evaluation of Commercial Quality/Production
Value
Informative Value of Commercial
Desire for Greater Information after Viewing
Commercial
Suggestions for Improving the Commercial
Other/Miscellaneous*

*This category included comments such as “I have no comments or feedback,” “I don’t have any,” etc.
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Appendix B
Rational, non-directive
Anxiety disorders are among the most common problems people face today. Anxiety can involve
feelings of worry, fear, and nervousness, as well as physical symptoms like muscle tension,
accelerated heartrate, and shortness of breath. For some people, these symptoms become so
frequent or severe that it can significantly impact the quality of their lives. Anxiety disorders can
cause individuals to have trouble with focus, concentration, and attention, as well as difficulty
with sleep, going certain places, or doing certain things.
Fortunately, there are treatment options that have been demonstrated to help lessen the effects of
anxiety. One of the most well-established treatments does not require any type of medication—
it’s called Cognitive-Behavioral Therapy (CBT). CBT is an approach which encourages the
individual to look at the connection between their thoughts and their feelings, and how these
factors influence how they live their lives. For example, someone who is suffering from an
anxiety disorder may have very worried thoughts about going into a public place, and even
thinking about leaving the house may result in feelings of fear, physical stress, and panic, which
impacts their quality of life.
A mental health professional trained in CBT may be able to help reduce these problems. A
cognitive-behavioral therapist can assist in developing new coping skills, gaining greater insight
into a person’s difficulties, and providing solutions to problems that may seem overwhelming.
Cognitive-behavioral therapy is usually a short-term treatment, often between 6 and 20 sessions,
that focuses on specific skills and issues, and for most insurance plans offer some coverage for
this treatment. More information about Cognitive-Behavioral Therapy is available online at
http://www.abct.org/Information
Rational, directive appeal
Anxiety disorders are among the most common problems people face today. Anxiety can involve
feelings of worry, fear, and nervousness, as well as physical symptoms like muscle tension,
accelerated heartrate, and shortness of breath. For some people, these symptoms become so
frequent or severe that it can significantly impact the quality of their lives. Anxiety disorders can
cause individuals to have trouble with focus, concentration, and attention, as well as difficulty
with sleep, going certain places, or doing certain things. If you or someone you know experience
these symptoms, it may be time to seek help.
Fortunately, there are treatment options that have been demonstrated to help lessen the effects of
anxiety. One of the most well-established treatments does not require any type of medication—
it’s called Cognitive-Behavioral Therapy (CBT). CBT is an approach which encourages the
individual to look at the connection between their thoughts and their feelings, and how these
factors influence how they live their lives. For example, someone who is suffering from an
anxiety disorder may have very worried thoughts about going into a public place, and even
thinking about leaving the house may result in feelings of fear, physical stress, and panic, which
impacts their quality of life.
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Don’t wait if you are experiencing problems like these. A mental health professional trained in
CBT may be able to help reduce these problems. A cognitive-behavioral therapist can assist in
developing new coping skills, gaining greater insight into a person’s difficulties, and providing
solutions to problems that may seem overwhelming. Cognitive-behavioral therapy is usually a
short-term treatment, often between 6 and 20 sessions, that focuses on specific skills and issues.
You can even find a provider on your insurance plan today. To get more information about
Cognitive-Behavioral Therapy, visit http://www.abct.org/Information
Emotional, non-directive appeal
Everyone gets nervous or worried from time to time, but sometimes those feelings can be
overwhelming. I know—I have an anxiety disorder. Anxiety disorders are one of the most
common problems people face today, and they involve feelings of worry, fear, and nervousness,
as well as physical symptoms like muscle tension, accelerated heartrate, and shortness of breath.
For me, these symptoms became so frequent and severe that it ruined my quality of life. My
anxiety interrupted my focus, concentration, and attention, and I had difficulty with sleep, going
certain places, and doing certain things.
Fortunately, there is relief. I came upon one of the most well-established treatments that does not
require any type of medication—it’s called Cognitive-Behavioral Therapy (CBT). CBT is an
approach which encourages the individual to look at the connection between their thoughts and
their feelings, and how these factors influence how they live their lives. For example, I had very
worried thoughts about going into a public place, and just thinking about leaving the house made
me stressed, fearful, and panicky, which prevented me from living the life I wanted.
I sought out a trained mental health professional knowledgeable in CBT. My cognitivebehavioral therapist helped me develop new coping skills, gain greater insight into my
difficulties, and suggested solutions to my problems that seemed overwhelming. I appreciated
that cognitive-behavioral therapy was a short-term treatment (typically between 6 and 20
sessions) and that we focused on specific skills and issues. Even better, most of the costs were
covered by my insurance plan! I am so glad for the relief I found, and all it took was a visit to
http://www.abct.org/Information
Emotional, directive appeal
Everyone gets nervous or worried from time to time, but sometimes those feelings can be
overwhelming. I know—I have an anxiety disorder. Anxiety disorders are one of the most
common problems people face today, and they involve feelings of worry, fear, and nervousness,
as well as physical symptoms like muscle tension, accelerated heartrate, and shortness of breath.
For me, these symptoms became so frequent and severe that it ruined my quality of life. My
anxiety interrupted my focus, concentration, and attention, and I had difficulty with sleep, going
certain places, and doing certain things. If you or someone you know has been feeling this way,
it may be time to seek help.
Fortunately, there is relief. I came upon one of the most well-established treatments that does not
require any type of medication—it’s called Cognitive-Behavioral Therapy (CBT). CBT is an
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approach which encourages the individual to look at the connection between their thoughts and
their feelings, and how these factors influence how they live their lives. For example, I had very
worried thoughts about going into a public place, and just thinking about leaving the house made
me stressed, fearful, and panicky, which prevented me from living the life I wanted. I decided to
do something about it.
Don’t wait if you are experiencing problems like these. I sought out a trained mental health
professional knowledgeable in CBT. My cognitive-behavioral therapist helped me develop new
coping skills, gain greater insight into my difficulties, and suggested solutions to my problems
that seemed overwhelming. I appreciated that cognitive-behavioral therapy was a short-term
treatment (typically between 6 and 20 sessions) and that we focused on specific skills and issues.
Even better, most of the costs were covered by my insurance plan! I am so glad for the relief I
found, and if you or someone you know needs help, don’t wait. You can find more information
at http://www.abct.org/Information
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C1. Advertising evaluation (Madden, Allen, & Twible, 1998)
Did this commercial make you feel…

Insulted?
not at all
1

very much so
2

3

4

5

6

7

Good?
not at all
1

very much so
2

3

4

5

6

7

Cheerful?
not at all
1

very much so
2

3

4

5

6

7

Irritated?
not at all
1

very much so
2

3

4

5

6

7

Pleased?
not at all
1

very much so
2

3

4

5

6

7

Repulsed?
not at all
1

very much so
2

3

4

5

6

7

Stimulated?
not at all
1

very much so
2

3

4

5

6
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7

Soothed?
not at all
1

very much so
2

3

4

5

6

7

Please describe the commercial you just watched.

unpleasant
1

pleasant
2

3

4

5

6

unlikable
1

likable
2

3

4

5

6

boring
1

2

3

4

5

6

2

3

4

5

6

7

artful
2

3

4

5

6

bad
1

7

tasteful

artless
1

7

interesting

tasteless
1

7

7

good
2

3

4

5

6

89

7

C2. Intent to Try/Recommend (Spears & Singh, 2004)
Please describe your overall feelings about CBT as described in the commercial you just watched.

unappealing
1

appealing
2

3

4

5

6

bad
1

good
2

3

4

5

6

unpleasant
1

2

3

4

5

6

7
favorable

2

3

4

5

6

unlikable
1

7
pleasant

unfavorable
1

7

7
likable

2

3

4

5

6

7

Imagine that you are anxious and describe your intent to try CBT.
never
1

definitely
2

3

4

5

6

definitely do not intend to try
1

definitely intend to try
2

3

4

5

6

very low interest in trying
1

2

3

4

5

6

7
definitely will try it

2

3

4

5

6

probably not try it
1

7
very high interest in trying

definitely not try it
1

7

7
probably will try it

2

3

4

5

6

7

Imagine someone you know is anxious and describe your intent to recommend CBT.

never
1

definitely
2

3

4

5

6

definitely do not intend to recommend
1

2

7
definitely intend to recommend

3

4

5
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6

7

very low interest in recommending
1

very high interest in recommending
2

3

4

5

6

definitely not recommend it
1

definitely will recommend it
2

3

4

5

6

probably not recommend it
1

7

7
probably will recommend it

2

3

4

5
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6

7

C3. Depression, Anxiety, and Stress Scale

DASS21
Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the statement
applied to you over the past week. There are no right or wrong answers. Do not spend too much time
on any statement.
The rating scale is as follows:
0
1
2
3

Did not apply to me at all
Applied to me to some degree, or some of the time
Applied to me to a considerable degree, or a good part of time
Applied to me very much, or most of the time
1

I found it hard to wind down

0

1

2

3

2

I was aware of dryness of my mouth

0

1

2

3

3

I couldn't seem to experience any positive feeling at all

0

1

2

3

4

I experienced breathing difficulty (eg, excessively rapid breathing,
breathlessness in the absence of physical exertion)

0

1

2

3

5

I found it difficult to work up the initiative to do things

0

1

2

3

6

I tended to over-react to situations

0

1

2

3

7

I experienced trembling (eg, in the hands)

0

1

2

3

8

I felt that I was using a lot of nervous energy

0

1

2

3

9

I was worried about situations in which I might panic and make
a fool of myself

0

1

2

3

10

I felt that I had nothing to look forward to

0

1

2

3

11

I found myself getting agitated

0

1

2

3

12

I found it difficult to relax

0

1

2

3

13

I felt down-hearted and blue

0

1

2

3

14

I was intolerant of anything that kept me from getting on with
what I was doing

0

1

2

3

15

I felt I was close to panic

0

1

2

3

16

I was unable to become enthusiastic about anything

0

1

2

3

17

I felt I wasn't worth much as a person

0

1

2

3

18

I felt that I was rather touchy

0

1

2

3

19

I was aware of the action of my heart in the absence of physical
exertion (eg, sense of heart rate increase, heart missing a beat)

0

1

2

3

20

I felt scared without any good reason

0

1

2

3
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21

I felt that life was meaningless

0
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1

2

3

C4. Recall Questions
What mental health problem did the advertisement focus on?
a.
b.
c.
d.

Depression
Anxiety
Alcoholism
Schizophrenia

What was the name of the therapy being advertised?
a.
b.
c.
d.

Interpersonal Therapy (IT)
Play Therapy (PT)
Cognitive Behavioral Therapy (CBT)
Pharmacotherapy (i.e., medication)

What website did the advertisement mention?
a.
b.
c.
d.

www.findatherapist.com
www.ABCT.org
www.treatdepression.com
www.EMDR.org
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C5. Recall questions at follow-up
What mental health problem did the advertisement focus on?
e.
f.
g.
h.

Depression
Anxiety
Alcoholism
Schizophrenia

What was the name of the therapy being advertised?
a.
b.
c.
d.

Interpersonal Therapy (IT)
Play Therapy (PT)
Cognitive Behavioral Therapy (CBT)
Pharmacotherapy (i.e., medication)

What website did the advertisement mention?
d.
e.
f.
d.

www.findatherapist.com
www.ABCT.org
www.treatdepression.com
www.EMDR.org

In the time since viewing the advertisement, did you research any of the information discussed?
a. Yes
b. No
In the time since viewing the advertisement, did you recommend to a friend or family member any of
the information discussed?
a. Yes
b. No
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